BJP Mental Health Guidelines from NICE
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crisp, A. H.
Right arrow Articles by Crutchfield, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crisp, A. H.
Right arrow Articles by Crutchfield, M.

The British Journal of Psychiatry 150: 355-358 (1987)
© 1987 The Royal College of Psychiatrists

Clomipramine and 'drive' in people with anorexia nervosa: an in-patient study

AH Crisp, JH Lacey and M Crutchfield
St George's Hospital Medical School, London.

Drugs can sometimes be helpful within the overall treatment and management of anorexia nervosa. In this study we have examined the impact of clomipramine on food and activity in anorectics engaged in a treatment programme enabling them to regain normal body weight. Consumption of the drug was associated with increased appetite, hunger and calorie consumption during the early stages of treatment. There was no impact on ultimate outcome. In this study it was evident that the drug was unnecessary for weight gain, but it may be helpful in other programmes, both short and long term, where the patient has sufficient trust (to tolerate the enhanced hunger experience) but is not involved in the same behavioural constraints. However, its possible value in such programmes has not been proven here. Meanwhile, we take our findings as further evidence that clomipramine increases drive behaviour and appetite in humans and may be beneficial in the treatment of affective disorders because of this effect.


This article has been cited by other articles:


Home page
 FocusHome page
Royal Australian and New Zealand College of Psychi
Australian and New Zealand Clinical Practice Guidelines for the Treatment of Anorexia Nervosa
Focus, October 1, 2005; 3(4): 618 - 628.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
Eating Disorders: Defining the Phenotype and Reinventing the Treatment
Am J Psychiatry, November 1, 1999; 156(11): 1673 - 1675.
[Full Text]

Home page
 JAMAHome page
K. A. Halmi
A 24-Year-Old Woman With Anorexia Nervosa
JAMA, June 24, 1998; 279(24): 1992 - 1998.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals
Copyright © 1987 The Royal College of Psychiatrists.